AppLabs, InnaPhase tie up on lab info solutions

HYDERABAD: AppLabs has entered into a strategic alliance with US-based InnaPhase Corporation, provider of Laboratory Information Management System (LIMS) technology solutions to the life sciences industry. The alliance would allow AppLabs to sell and distribute the Watson LIMS product to the pharmaceutical, biotech and bulk drug organizations in India.

AppLabs has its offshore development center based in Hyderabad and the marketing of these products would be taken care by the Hyderabad center.

The Watson LIMS system is specifically designed to support DMPK/Bio-analytical studies in drug development while ensuring regulatory compliance with the FDA’s 21 CFR Part 11 guidance on electronic records and signatures. Watson has an established track record of accelerating bio-analysis, sample management and regulatory compliance in pharmaceutical drug development.

"AppLabs has a proven track record of delivering high quality, cost-effective solutions to the healthcare and life sciences markets," said Jo Webber, Ph.D., CEO of InnaPhase Corporation. "We are confident that this partnership will benefit both organizations as well as provide Indian life sciences organizations with best-in-class technologies that will enhance their bioanalytical research needs," he added.

"We are excited to bring world class products such as Watson LIMS to the Indian life sciences industry, said Sashi Reddi, CEO of Applabs. "We believe that by adopting internationally recognized platforms for conducting and managing research, Indian organizations will be better equipped to compete in the worldwide life sciences market."

By leveraging its offshore development center based in Hyderabad, India, AppLabs is able to provide cost-effective IT services in software testing and development. AppLabs is ISO 9001 certified and is currently implementing process improvements to become CMM Level 5 compliant.